NovaBridge Biosciences.

IMAB · NASDAQ

$1.43+$0.125 (+9.62%)TodayMarket closed ·
Prev close $1.30

Key indicators

IMAB profitability and balance sheet ratios

EPS -$0.0293 in Jun 2025, down 121.8% on a year earlier.

EPS by quarter
PeriodEPS
Jun 2023-$0.5864
Dec 2023-$0.50
Mar 2024-$0.086
Jun 2024$0.1344
Sep 2024-$0.107
Dec 2024-$0.0484
Mar 2025-$0.0168
Jun 2025-$0.0293

Income statement

No financial statements are reported for NovaBridge Biosciences..

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.